USMJ to Acquire ALYI Cannabis Point of Sale System Technology and ALYI to Acquire Lithium IP Company
May 31 2017 - 9:59AM
InvestorsHub NewsWire
Dallas, TX -- May 31, 2017
-- InvestorsHub NewsWire -- North American Cannabis
Holdings, Inc. (USOTC:
USMJ) today announced a deal shift in the planned
transaction with Alternet Systems, Inc. (USOTC:
ALYI). The change is a result of the impending
acquisition of the controlling interest in USMJ by American Cannabis Innovations
Conglomerated (“ACI”). The ACI acquisition is
part of ACI’s overall strategy to acquire early stage, undervalued
businesses with intellectual properties validated by market tests,
and commercial or consumer sales. ACI wants the ALYI Cannabis
Point of Sale (POS) System to undergo further market testing before
it stands alone under its own public listing. Accordingly, an
agreement has been reached for USMJ to acquire the Cannabis POS
technology outright without including a swap of ALYI equity as
previously contemplated. USMJ will conduct further pilot
market testing of the Cannabis POS system to better prepare for a
future spinoff and independent listing of a Cannabis POS system.
Alternatively, ALYI has entered into an
agreement to go a different direction acquiring a private Lithium
Intellectual Property Company that has entered into a strategic
agreement with Lithium Exploration Group, Inc. (USOTC: LEXG) among
other strategic developments. Look for more updates soon
on USMJ’s plans for the Cannabis POS system and ALYI’s new Lithium
business strategy.
Learn More About
USMJ:
growusmj.com
Disclaimer/Safe Harbor: This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies’ contracts, the companies’ liquidity position, the
companies’ ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure or prevent any disease.
North American Cannabis Holdings Contact:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com